Provivi
ActiveOn the Biological inputs Radar · not rankedManufactures insect pheromones at lower cost through chemical-biological synthesis and sells mating-disruption products to row-crop farmers to control pests such as fall armyworm.
Why Provivi is not ranked yet
How the Radar works →The Radar lists every known eligible company, sorted by date of last round, with no AI judgement. Provivi enters the ranking once its public data is sufficient for the AI to estimate it. Next Biological inputs worldwide edition: 12 Feb 2027.
Funding history
| Date | Round | Amount | Type | Investors |
|---|---|---|---|---|
| 2019 | Series C | USD 85M | Equity | Pontifax AgTech |
No later round found.
Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.
Uback rankings
How the AI ranks →| Ranking | Tier | Rank | Edition | Next update |
|---|---|---|---|---|
| Biological inputs · worldwide | Radar | — | Edition 0 · Oct 2026 | 12 Feb 2027 |
Independent analyses
By industry professionals & analystsIndustry professionals and financial analysts can publish their own analysis of Provivi as a PDF. It must answer at least one of these four questions, and stick to them:
Analyses are the opinion of their authors, not of Uback. They are checked before publication.
Comparable companies in biological inputs
Full biological inputs ranking →Investors in Provivi: Pontifax AgTech
Last updated: Oct 2026Report an error
Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.